Your browser doesn't support javascript.
loading
Considering gemcitabine-based combination chemotherapy as a potential treatment for advanced oesophageal cancer: A meta-analysis of randomised trials.
Yang, Jian; Liang, Xiao; Zhai, Yuanfang; Hu, Xiaoling; Jia, Zhiwu; Cheng, Xiaolong.
Afiliação
  • Yang J; Translational Medicine Research Center, Shanxi Medical University, Taiyuan, PR China.
  • Liang X; Department of Pathology & Shanxi Key Laboratory of Carcinogenesis and Translational Research on Esophageal Cancer, Shanxi Medical University, Taiyuan, PR China.
  • Zhai Y; Department of Pathology & Shanxi Key Laboratory of Carcinogenesis and Translational Research on Esophageal Cancer, Shanxi Medical University, Taiyuan, PR China.
  • Hu X; Department of Anatomy, Shanxi Medical University, Taiyuan, PR China.
  • Jia Z; Department of Pathology & Shanxi Key Laboratory of Carcinogenesis and Translational Research on Esophageal Cancer, Shanxi Medical University, Taiyuan, PR China.
  • Cheng X; Department of Anatomy, Shanxi Medical University, Taiyuan, PR China.
Int J Clin Pract ; 74(7): e13510, 2020 Jul.
Article em En | MEDLINE | ID: mdl-32279393
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Desoxicitidina / Recidiva Local de Neoplasia / Antimetabólitos Antineoplásicos Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Desoxicitidina / Recidiva Local de Neoplasia / Antimetabólitos Antineoplásicos Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article